Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Denervation vs Spironolactone in Resistant Hypertension
NCT02039492Completed
- Sponsor
- Parc de Salut Mar
- Start
- Sep 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Changes in ambulatory 24h-systolic blood pressure at 6 months. Started Sep 2012; status: completed.
Beyond the preview
Go deeper on NCT02039492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039492.